Clinical significance of the detection of antinuclear antibodies in patients with acute hepatitis A

Gut and Liver

Volumn 5, Issue 3, 2011, Pages 340-347

  Seo, Yeon Seok ^a   Lee, Kwang Gyun ^a   Jung, Eun Suk ^a   An, Hyonggin ^a   Kim, Ji Hoon ^a   Yeon, Jong Eun ^a   Byun, Kwan Soo ^a   Yim, Hyung Joon ^a   Lee, Hong Sik ^a   Um, Soon Ho ^a   Kim, Chang Duck ^a   Ryu, Ho Sang ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Autoimmune; Clinical outcome; Complication; Hepatitis A

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; BILIRUBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; FEMALE; FULMINANT HEPATIC FAILURE; HEPATITIS A; HOSPITAL PATIENT; HUMAN; IMMUNOFLUORESCENCE; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RELAPSE; SEX DIFFERENCE;

EID: 80052474791     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.3.340     Document Type: Article

References (28)

1. Berlin T., Zandman-Goddard G., Blank M., et al. Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci 2007;1108:584-593. (Pubitemid 47528772)
2. Andersen P., Andersen H.K. Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection. Clin Exp Immunol 1975;22:22-29.
3. Andersen P. Correlation of smooth-muscle and nuclear antibodies in normal subjects. Clin Exp Immunol 1977;27:74-77. (Pubitemid 8017273)
4. Muratori P., Muratori L., Guidi M., et al. Clinical impact of non-organ- specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis 2005;40:501-507. (Pubitemid 40270217)
5. Lenzi M., Bellentani S., Saccoccio G., et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: A nested case-control study of the Dionysos cohort. Gut 1999;45:435-441. (Pubitemid 29400723)
6. Cassani F., Cataleta M., Valentini P., et al. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-566. (Pubitemid 27392344)
7. Peng Y.C., Hsieh S.C., Yang D.Y., et al. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection. J Clin Gastroenterol 2001;33:402-406.
8. Hsieh M.Y., Dai C.Y., Lee L.P., et al. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. J Clin Pathol 2008;61:333-337.
9. Stroffolini T., Colloredo G., Gaeta G.B., et al. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 2004;11:257-262. (Pubitemid 38658451)
10. Williams M.J., Lawson A., Neal K.R., Ryder S.D., Irving W.L.; Trent H.C.V. Group. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat 2009;16:325-531.
11. Song D. B.C.G. vaccination in Korea. Bull Int Union Tuberc 1972;47 Suppl 2:165-167.
12. Gutierrez A., Chinchilla V., Espasa A., Perez-Mateo M. Transient positivity of antinuclear and anti-smooth muscle antibodies in hepatitis A virus infection. J Hepatol 1996;24:123. (Pubitemid 26035986)
13. Moon H.W., Noh J.K., Hur M., Yun Y.M., Lee C.H., Kwon S.Y. High prevalence of autoantibodies in hepatitis A infection: the impact on laboratory profiles. J Clin Pathol 2009;62:786-788.
14. Vento S., Garofano T., Di Perri G., Dolci L., Concia E., Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991;337:1183-1187.
15. Rahaman S.M., Chira P., Koff R.S. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol 1994;89:106-108. (Pubitemid 24020062)
16. Huppertz H.I., Treichel U., Gassel A.M., Jeschke R., Meyer zum Büschenfelde K.H. Autoimmune hepatitis following hepatitis A virus infection. J Hepatol 1995;23:204-208.
17. Skoog S.M., Rivard R.E., Batts K.P., Smith C.I. Autoimmune hepatitis preceded by acute hepatitis A infection. Am J Gastroenterol 2002;97:1568-1569. (Pubitemid 34664819)
18. Hilzenrat N., Zilberman D., Klein T., Zur B., Sikuler E. Autoimmune hepatitis in a genetically susceptible patient: Is it triggered by acute viral hepatitis A? Dig Dis Sci 1999;44:1950-1952. (Pubitemid 29510800)
19. Grunhage F., Spengler U., Fischer H.P., Sauerbruch T. Autoimmunehepatitis: sequel of a relapsing hepatitis A in a 75-year-old woman. Digestion 2004;70:187-191.
20. Sherlock S., Dooley J. Viral hepatitis: general features, hepatitis A, hepatitis E and other viruses. In: Sherlock S, Dooley J, eds. Diseases of the liver and biliary system. 11th ed. Oxford: Blackwell Science, 2002:267-283.
21. Tong M.J., el-Farra N.S., Grew M.I. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995;171 Suppl 1:S15-S18.
22. Holborow E.J., Johnson G.D., Farrow L.J., Zuckerman A.J., Taylor P.E. Immunofluorescent detection of autoantibodies in the sera of acute infective hepatitis patients. Ann N Y Acad Sci 1971;177:214-217.
23. Yoon Y.K., Chun B.C., Lee H.K., et al. Epidemiological and genetic analysis of a sustained community-wide outbreak of hepatitis A in the Republic of Korea, 2008: a hospital-based case-control study. J Clin Virol 2009;46:184-188.
24. Seligmann M., Cannat A., Hamard M. Studies on antinuclear antibodies. Ann N Y Acad Sci 1965;124:816-832.
25. Svec K.H., Veit B.C. Age-related antinuclear factors: immunologic characteristics and associated clinical aspects. Arthritis Rheum 1967;10:509-516.
26. Shu S., Nisengard R.J., Hale W.L., Beutner E.H. Incidence and titers of antinuclear, antismooth muscle, and other autoantibodies in blood donors. J Lab Clin Med 1975;86:259-265.
27. McCarthy M. The "gender gap" in autoimmune disease. Lancet 2000;356:1088.
28. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001;2:777-780.